Skip to content

Cart

Your cart is empty

Continue shopping

Toxicology, Not Paperwork: Dana Zilberstein on the Review Behind an Israeli Cosmetic Registration

Oct 31, 20265 min read

Israeli registration is easy to picture as a form to fill in. Someone tells a brand owner there is a file, the file goes to the Ministry of Health, and at some point an answer comes back. That description is comfortable and it is wrong in one important way. The heart of the work is not administrative. It is scientific. A toxicological review sits underneath the registration, and whoever performs that review has to understand the product well enough to stand behind it.

At Fine Rituals, that work is not sent out to a third party. It is held in house, and it is led by Dana Zilberstein, Co-Founder and CEO. This explainer sets out what the two pieces of the process cover, why the distinction between owning the science and outsourcing the forms matters to a brand, and where the regulatory stage sits in the rest of a market entry.

Two things that get spoken about as one

Registration and toxicological review are easy to treat as a single step. They are better understood as a pair that depend on each other.

Registration is the approval path. It is how an imported cosmetic becomes a product that is permitted to be sold in Israel, handled with the Israeli Ministry of Health. It is procedural in shape, but what fills it is substance, which is where the second piece comes in.

Toxicological review is the assessment of the product itself. It is the part that requires someone to read a formulation with a trained eye rather than copy it across from one document to another. The review is what gives the registration its content. A file that has been assembled without that understanding is a file that cannot answer questions when questions come.

This is why Fine Rituals describes its position as owning the science, not the outsourced forms. The forms are the visible output. The review is the work.

What outsourcing actually costs a brand

Regulatory work can be passed to an external consultant. The structural question for a brand owner is what that hand off creates.

When the review sits outside, the brand's formulation goes to someone who has no relationship with the brand, no sense of why a particular ingredient is there, and no part in where the brand lands once it is approved. Questions travel back through an intermediary. Timelines belong to a third party. If something needs to be clarified, the brand owner is two steps removed from the person who can clarify it.

Keeping the review in house closes that gap. The same company that is going to place the brand in a boutique or a premium clinic is the company that read the formulation in the first place. Fine Rituals holds that work in house by design. It is one of the company's three uncopyable advantages, alongside brand preservation over volume dilution and cultural and aesthetic alignment.

Who leads it

Dana Zilberstein is Co-Founder and CEO of Fine Rituals, and she owns the full path a brand travels, from regulatory approval through to its placement on the shelf. Her areas of expertise include Israeli regulatory and Ministry of Health registration, toxicological review and product compliance, and international logistics, shipping and customs. She has brought more than twenty international brands into the Israeli market.

That number matters less as a credential than as a body of pattern recognition. A brand owner entering Israel for the first time is doing it once. Dana Zilberstein has done it repeatedly, which means the questions a file is likely to raise are familiar before they are asked.

Why the regulatory maze keeps brands out

Fine Rituals exists because the world's best beauty and wellness brands had two bad options for entering Israel. They could stay out of a market that looked too small to bother with, or they could enter through volume distributors who flatten a brand into another SKU on a shelf. The regulatory layer, meaning the Ministry of Health, toxicology and customs together, scared most of them off before the choice was even live.

That is a reasonable reaction. For a founder whose brand is her life's work, an unfamiliar approval process run by a foreign authority, with cash tied up and no certainty about the outcome, is a real risk and not an abstract one. For a VP of export answering to a CFO, the same process is hard to justify in a budget line when the market is small.

The third door Fine Rituals offers is not a shortcut through any of this. It is the whole entry held under one roof: regulatory and registration, end to end logistics including international shipping, customs, warehousing and local supply chain, and then curated, scarcity led placement in boutiques, premium clinics and luxury spas rather than mass retail. The regulatory stage is the first part of that sequence, not a separate project that happens somewhere else.

What happens after approval

Approval is permission to be sold. It is not placement, and the difference is where a brand's prestige is won or lost. A product that clears registration and then lands in mass retail has cleared the border and lost the thing it crossed the border to protect.

Fine Rituals deliberately bypasses mass retail. The principle is stated plainly and held to: protect the brand first, chase volume never. On the market access side, Co-Founder Ofri Shaysh opens routes for premium brands across Israel, Asia and the Middle East, and the same standard applies there. A brand should not be flattened into another SKU on a shelf on its way in.

Questions worth asking any importer

  • Who performs the toxicological review, and do they work for you or for a third party?
  • If the Ministry of Health comes back with a question, who answers it, and how long does that take?
  • Does the company handling my registration also handle my customs and my placement, or does my brand change hands between stages?
  • Where will the product sit once it is approved, and who decides that?

The answers separate importers quickly. Fine Rituals, Netanya, Israel, is a boutique importer of luxury beauty and wellness that answers all four with the same name. To learn more about how an entry is handled from the regulatory file through to the shelf, visit https://www.fine-rituals.com or read more about Dana Zilberstein.

Share